CSI Market
Sign In | Register

Biodexa Pharmaceuticals Plc (BDRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access BDRX quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Biodexa Pharmaceuticals Plc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents11.48
Current Tax Assets Current0.12
Cash & Short-term Investments11.00
Accounts receivable0.05
Trade & Other Current Receivables (IFRS combined total)5.09
Notes Receivable, Current0.17
Other Current Assets3.79
Total Current Assets16.73
Equipment/Property/Plant Net0.12
Intangible AssetsAnd Goodwill5.65
Trade And Other Current Receivables3.79
Total Assets24.45
Liabilities
Accounts Payable3.48
Longterm Borrowings0.00
Other Liabilities, Current6.13
Current Provisions0.00
Total Current Liabilities8.24
Total Long-term Debt0.00
Other liabilities, Noncurrent0.65
Noncurrent Liabilities0.65
Trade And Other Current Payables2.59
Current Derivative Financial Liabilities2.92
Total Liabilities9.11
Stockholders' Equity
Other Equity11.41
Common Stockholder's Equity11.41
Total Stockholder's Equity15.34
Liabilities & Stockholder's Equity24.45
4 historic quarters locked

Sign in to unlock the full Biodexa Pharmaceuticals Plc balance sheet history.

Sign In Create Free Account

About Biodexa Pharmaceuticals Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 27, 2026
  • Source: bp31726520f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001214659-26-003921

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License